ArticleAnais brasileiros de dermatologia

Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study.

Ilteris Oguz Topal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.